R/R B-Cell Acute Lymphoblastic Leukemia

Pediatric Oncology Treatment of Pediatric Patients with Relapsed and Refractory B-Cell Acute Lymphoblastic Leukemia with Inotuzumab Ozogamicin: A Single-Center Experience
Dmitrii Evstratov • Ekaterina Sitnova • Ludmila Vavilova • Yulia Diakonova • Larisa Shelikhova
doi.org/10.69690/ODMJ-018-0425-1248